Yoshinori Imamura

11PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGeriatrics and gerontologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 06, 2025
Negative Impact of Coronavirus Disease 2019 Pandemic on Gastric Cancer Care in Japan: A Tokushukai Real-World Data Project 08 (TREAD 08).

Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu

|Sep 30, 2024
Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008.

Yoshinori Imamura, Naomi Kiyota, Makoto Tahara

|Sep 20, 2024
Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01.

Makoto Hibino, Yoshinori Imamura, Rai Shimoyama

|Apr 07, 2024
Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.

Kiyoaki Uryu, Yoshinori Imamura, Rai Shimoyama

|Nov 24, 2023
Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01).

Kiyoaki Uryu, Yoshinori Imamura, Rai Shimoyama

|Nov 11, 2022
Real-World Outcomes of Systemic Therapy in Japanese Patients with Cancer (Tokushukai REAl-World Data Project: TREAD): Study Protocol for a Nationwide Cohort Study.

Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu

Pageof 2

Frequent Collaborators

4 joint publications

Rai Shimoyama

3 joint publications

Hironobu Minami

2 joint publications

Masataka Taguri

2 joint publications

Kiyoaki Uryu